Protagonist Therapeutics

Protagonist Therapeutics

World Rank (Aug-2026)
2204
Market Cap (Aug-2026)
10.036 Billion USD
World Rank (Jan-05-2024)
7,332
Market Cap (Jan-05-2024)
1.316 Billion USD
World Rank (Jul-30-2023)
8,303
Market Cap (Jul-30-2023)
1.093 Billion USD
World Rank (Jan-07-2022)
7,030
Market Cap (Jan-07-2022)
1.664 Billion USD
World Rank (Jan-01-2021)
8,606
Market Cap (Jan-01-2021)
0.855 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
PTGX
Employee Count
105
Employee Count as of Date
As on 2022
Headquarters City/State
California
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
46 Million USD
Annual Operating Income in USD
-158 Million USD
Annual Net Income in USD
-130 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
668 Million USD
Total Liabilities in USD
53 Million USD
Total Equity in USD
615 Million USD
Balance Sheet for Period Ending
As of December-2025
Business Sector
Healthcare
HealthCare Products
Biotechnology
Biopharmaceutical
Company Website
PROTAGONIST THERAPEUTICS
Yahoo
Yahoo @ Stuttgart
Company Profile

Protagonist Therapeutics is a Clinical Stage Biopharmaceutical company with multiple peptide based new chemical entities in different stages of development. The headquarters is in USA.

Facts About Company

Protagonist Therapeutics Annual Total Revenue for year ending Dec-2022 was 26 million USD and and Net loss for year ending Dec-2022 was -127 million USD.

Protagonist Therapeutics Annual Total Revenue for year ending Dec-2021 was 27 million USD and and Net loss for year ending Dec-2021 was -125 million USD.

As on 2022, Protagonist Therapeutics has 105 employees.

IPO Year
2016
Stock Exchange
Nasdaq
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share